Data were obtained from OVERCOME 2018, a web-based survey conducted in the US. The study identified persons with migraine based on ICHD-3 criteria assessed with a validated diagnostic screener or self-reported medical migraine diagnosis. Results are presented by total and were also categorized by monthly headache day groups (0-3, 4-7, 8-14, ≥15).

Of the 21,143 participants with migraine, 12,212 (57.8%) had headache-related disability (MIDAS ≥6). Only 63% of the those sought care and among those, 75.4% were diagnosed with migraine. Among those who sought care and were diagnosed, 58.6% were taking a recommended acute prescription for migraine. Overall, only 27.9% of the total sample had gone through all these steps. For care seeking, there were differences for nearly all factors assessed (p<0.001). Overall, 10.6% of those who sought care did so only at an Emergency Department and/or Urgent Care and/or Retail Clinic (ED/UC/Retail). Factors differentiating diagnosis included being female (Diagnosed=76.8% vs Not Diagnosed=70.2%, p <0.001), and having sought care at ED/UC/Retail only (Diagnosed=9.1% vs Not Diagnosed=15.3%, p<0.001). Factors differentiating receiving a recommended acute prescription for migraine included having severe (MIDAS≥21) headache-related disability (Prescribed=55.5% vs Not Prescribed=49.6%, p<0.001), and having sought care at ED/UC/Retail only (Prescribed=5.7% vs Not Prescribed=13.9%, p<0.001). These findings varied across monthly headache day groups.

There remain unmet needs across monthly headache day groups for providing potentially effective acute prescription treatment for migraine.